SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193805-24-000364
Filing Date
2024-03-14
Accepted
2024-03-14 09:05:02
Documents
14
Period of Report
2024-03-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e619365_8ka-arct.htm   iXBRL 8-K/A 28925
  Complete submission text file 0001193805-24-000364.txt   206165

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE arct-20240307.xsd EX-101.SCH 3021
3 XBRL LABEL FILE arct-20240307_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE arct-20240307_pre.xml EX-101.PRE 22363
15 EXTRACTED XBRL INSTANCE DOCUMENT e619365_8ka-arct_htm.xml XML 4083
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38942 | Film No.: 24748083
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)